POS1113 ANTIRESORPTIVE THERAPY AFTER TERIPARATIDE DISCONTINUATION – WHEN IS THE BEST TIME TO STARTING IT?
M. Rato(Hospital de São João), Lúcia Costa(Hospital de São João), M. Bernardes, Diogo Fonsêca(Centro Hospitalar de Vila Nova de Gaia), A. Bernardo(Hospital de São João), S. Garcia(Hospital de São João), F. R. Martins(Algarve Biomedical Center), F. Oliveira Pinheiro(Universidade do Porto), D. Santos Oliveira, A. Martins(Hospital de São João), Raquel Ferreira(Hospital de São João), Bruno Miguel Fernandes(Hospital de São João)
Cited by 1
Related Papers
Tumor Protein p53‐Induced Nuclear Protein (TP53INP1) Expression in Medullary Thyroid Carcinoma: A Molecular Guide to the Optimal Extent of Surgery?
|World Journal of Surgery|2010|10
Oculomotor nerve palsy, an unusual onset of polyarteritis nodosa
|Reumatologia/Rheumatology|2023|5
SAT0465 FRACTURE RISK ASSESSMENT BY FRAX IN A SYSTEMIC LUPUS ERYTHEMATOSUS PORTUGUESE COHORT
|Annals of the Rheumatic Diseases|2020|4
Creation and Validation of a Portuguese Version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
|International Journal of Environmental Research and Public Health|2023|3